Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions. [electronic resource]
Producer: 20050519Description: 118-9; author reply 119 p. digitalISSN:- 0306-5251
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Antidepressive Agents, Tricyclic -- adverse effects
- Aryl Hydrocarbon Hydroxylases -- antagonists & inhibitors
- Cytochrome P-450 CYP2C9
- Drug Combinations
- Gastrointestinal Diseases -- chemically induced
- Humans
- Selective Serotonin Reuptake Inhibitors -- adverse effects
No physical items for this record
Publication Type: Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.